Study of mechanism of atrial fibrillation and comparison of ablation and pharmacological therapy (SMAF-CAPT) :rationale and design
黄从新,张澍,马长生,江洪,黄鹤,吴钢,李红良,唐艳红,杨波
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2014.03.002
2014-01-01
Abstract:Background Mechanism of atrial fibrillation (AF) is still unclear,its related genes and upstream regulatory mechanisms should be studied.The major treatments of AF include pharmacological therapy (PT) and catheter ablation (CA),and it has been proved that CA is more suitable than PT,but our own clinical data remain unknown.The purpose of SMAF-CAPT is to explore the mechanism of AF and its suitable treatments strategy.The study consists of two parts:①study of mechanism of atrial fibrillation (SMAF),②comparison of ablation and pharmacological therapy (CAPA).Rationale ①SMAF study:Cardiac electrophysiology can be upstream regulated in many aspects and links,such as neurotransmitters,protein kinases,G proteins,the relation between them and arrhythmia has been increasingly taken seriously.Our previous studies have demonstrated that regulator of G protein signaling 5 (RGS5) is closely related by cardiac hypertrophy and arrhythmias.Furthermore,it also finds that micro RNA (miRNA) is closely associated with arrhythmia,which provides a new direction for upstream regulation of arrhythmia.In recent years,it has been proved patients with refractory hypertension can get benefits from renal sympathetic denervation (RDN),which can change the autonomic nervous system and thus may affect the occurrence and maintenance of AF.However,the exact effect and mechanism are unclear,and the influence to RDN on atrium matrix remodeling also needs attention.Screen AF-related genes by genetic engineering technique,and then establish animals models of specific genes modification,SMAF aims to explore the feasibility and targets of upstream regulation to AF.And to study the impact and mechanisms of RDN on trigger and maintenance of AF.②CAPA Study:Pharmacological treatment (PT) can partly maintain the sinus rhythm,or improve the symptoms of patients with chronic heart failure,but its long-term effects seem poor.The strategy of ventricular rate control has no significant benefit on the quality and long-term survival rate.Catheter ablation (CA),which has developed rapidly and became the best means of rhythm control.CAPA aims to compare the pros and cons of both treatments by prospective study.Design ①SMAF includes two aspects,One is to get atrial tissue from patients with AF,and search AF-related genes by genetic screening technology.According to the results,we will validate and construct the corresponding transgenic animals.Then,to conduct electrophysiological studies.The other is to build the models of acute and chronic AF,and observe the conditions of occurrence and maintenance of AF before and after RDN.Then,explore the influence of RDN on electrical remodeling,structural remodeling,nerve remodeding,atrial matrix,and investigate the corresponding molecular mechanism.②CAPA also consists of two parts of paroxysmal AF and persistent AF.Six hundred patients (a total of 1 200 cases) will be included in each part,and divided into pharmacological treatment group (PTG) and catheter ablation group (CAG).PTG can implement as long as physicians can use drugs as medical guide,and whether ventricular rate control or rhythm control strategy relies on the advice of physicians and the will of patients.Primary endpoints of the study includes stroke,peripheral vascular embolic events,bleeding,malignant arrhythmia (hemodynamic disorders resulted to rapid atrial rate,ventricular tachycardia,ventricular fibrillation),hospitalization of heart failure and so on.The second endpoints are cardiovascular events and total mortality.Conclusion Write the result of upstream regulation and automatical nerve intervention,SMAF study will provide new ideas,methods,and scientific basis for prevention and treatment of AF.Based on our national data,CAPA study will illustrate the more advantageous strategy,and thus to provide the basis for the management systems in the national level.